Paul Wozniak of Park City Angels will be speaking to us on The Funding Panel next week. Here’s your chance to Meet The Angel before the event:

The Park City Angels are a newly formed group of accredited investors located in Park City, Utah. The Park City Angels are looking to invest in promising opportunities that can produce significant shareholder return.

The active lifestyle of Park City has attracted many dynamic and successful business leaders that have deep experience in building world class businesses. The Park City Angels facilitate unique, high-caliber networking and development forums for angel investors and mentors involved in early-stage investment. Our mission is to promote best practice in order to reduce risk in early-stage investments for the benefit of entrepreneurs, investors and the community.

Our members are drawn from private groups, including investors and mentors who are interested in supporting and/or financing early-stage ventures. Our members have in common a strong desire, willingness, and capability to support ventures where they can work with management in the local region. We invest in areas where we believe our group can be a true value-added investor.

Within our group is an environment where self help and comradery predominate and where angels can develop confidence in their early-stage investment skills.

Early-stage investing today is analogous to the early days of the stock market where railways and gold mining stocks attempted to attract scarce investment dollars. Clever people made their fortunes during these exciting times. The Park City Angels provide an environment where investors can develop a clever approach to early-stage investment.

Scott Frazier of Utah Angels will be speaking to us on The Funding Panel next week. Here’s your chance to Meet The Angel before the event:

Scott Frazier is an angel investor and co-founder of the Utah Angels.

Frazier’s major investments include TruVision, Omniture, MyFamily.com, Corda Technologies, iCentral, Thoughtstar, Infopia, and Cerberian. Frazier serves as president of TruVision, Inc., a rapidly growing company that operates nationwide, preferred-rate provider networks for Lasik, cosmetic surgery, and hearing aids.

From 1987 to 1995, he was co-owner and CEO of Achievement Rehab, a leading provider of contract therapy to nursing homes.

Frazier grew this company from 150 employees to 2,000 employees and $100 million in revenues, prior to selling in 1995.

Frazier earned a BA in economics from BYU in1975 and an MBA from Harvard in 1978. He and his wife, Miriam, have eight children.

Todd Dauphinais of Olympus Angels will be speaking to us on The Funding Panel next week. Here’s your chance to Meet The Angel before the event:

Prior to joining Aster Capital in September 2010, Todd held various positions in General Management, Corporate Development and Strategic Consulting; Most recently as the President and General Manager of EFI Electronics where he oversaw the firm’s record growth in revenues and profitability.

Prior to this role, Todd spent five years with the Corporate Development / M&A teams at both Schneider Electric and Rockwell Automation and seven years with the Strategy & M&A practice at Deloitte Consulting with a focus on providing advice to the firm’s Energy & Utility clients. Throughout his career, Todd has closed or advised on over 20 M&A transactions in North America and Asia.

Todd holds an Masters of Business Administration from the University of Notre Dame and a Bachelors of Business Administration with a specialization in Finance from Texas A&M University.

Todd leads Aster Capital activities in the US and manages the investments in Agilence and SemiSouth.

Andrew Laver of Salt Lake Life Science Angels will be speaking to us on The Funding Panel next week. Here’s your chance to Meet The Angel before the event:

Andrew Laver is currently the Managing Director of APL Capital Advisors.

Prior to founding APL Capital, Andrew gained investment and transactional experience in the venture capital and private equity industries.

Andrew also has an operations and technical background having worked as an engineering project manager at the Abbott Laboratories Hospital Products Division and as a research assistant at the University of Utah. He holds Series 7, 63, & 79 securities licenses.

Andrew has a MBA (with distinction) from New York University, and a MS in Bioengineering from the University of Utah. He also holds bachelor’s degrees (cum laude) in Electrical Engineering and Asian Studies from the University of Utah.